Company Filing History:
1 out of 832,891 Years Active: 2013
Title: Innovations in Colorectal Cancer Detection by Changming Fang
Introduction
Changming Fang is an accomplished inventor based in La Jolla, California. He has made significant contributions to the field of medical diagnostics, particularly in the detection of colorectal cancer. His innovative work has the potential to improve early diagnosis and treatment options for patients.
Latest Patents
Changming Fang holds a patent for "Compositions and methods for detection of colorectal cancer." This patent identifies a new variant of ileal bile acid binding protein (IBABP), designated IBABP-L, which serves as a biomarker for colorectal cancer. The discovery includes details about the transcript for IBABP-L, which arises from an alternative start site and contains three exons that are absent in the original IBABP. Notably, IBABP-L shares part of a fourth exon with IBABP. The protein encoded by IBABP-L features a unique 49 residue N-terminal sequence not found in the IBABP protein. This invention provides methods for diagnosing colorectal cancer and other related compositions and methods based on this groundbreaking discovery.
Career Highlights
Throughout his career, Changming Fang has focused on advancing medical diagnostics. His work has been recognized for its potential impact on patient care and treatment outcomes. He continues to explore innovative solutions in the field of cancer detection.
Collaborations
Changming Fang has collaborated with Jeffrey W. Smith, contributing to the development of his patented technologies. Their partnership highlights the importance of teamwork in advancing scientific research and innovation.
Conclusion
Changming Fang's contributions to colorectal cancer detection exemplify the vital role of inventors in the medical field. His innovative approaches have the potential to transform diagnostic practices and improve patient outcomes.